Treatment efficacy also correlated with a molecular smoking signature(higher transversion vs.transition mutations),a higher candidate neoantigen burden,and mutations in DNA repairpathwagenes.
Treatment efficacy also correlated with a molecular smoking signature(higher transversion vs.transition mutations),a higher candidate neoantigen burden,and mutations in DNA repairpathwagenes.<br>